CD20 antibody–based combination therapy may reduces the adverse prognostic impact of M-protein positivity in marginal zone lymphoma

Yajun Zhang, Wanqian Hu, Ying Fang, Bo Zheng, Yi Zhang, Wenda Chen, Rong Li

doi:10.1016/j.lrr.2026.100616

CrossrefInfo card

CD20 antibody–based combination therapy may reduces the adverse prognostic impact of M-protein positivity in marginal zone lymphoma

Yajun Zhang, Wanqian Hu, Ying Fang, Bo Zheng, Yi Zhang, Wenda Chen, Rong Li

Leukemia Research Reports · 2026 · 26 · 100616

DOI: 10.1016/j.lrr.2026.100616 ↗

Abstract Bibliographic details

Abstract

No abstract available.

Bibliographic details

Authors: Yajun Zhang, Wanqian Hu, Ying Fang, Bo Zheng, Yi Zhang, Wenda Chen, Rong Li
Journal: Leukemia Research Reports
Year of publication: 2026
Volume / Issue: 26
Pages: 100616
Publisher: Elsevier BV
DOI: 10.1016/j.lrr.2026.100616
ISSN: 2213-0489
Source: Crossref

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.